Pancreatic Intraductal Neoplasms

Oncology·MeSH: Pancreatic Intraductal Neoplasms

Prevalence

3358.2 / 100K

Incidence

1547.2 / 100K/yr

0 drugs in development·0 companies·1 clinical trial

Frequently asked questions

How many clinical trials target Pancreatic Intraductal Neoplasms?

There are 1 clinical trial targeting Pancreatic Intraductal Neoplasms tracked by BioSniper.

What is the prevalence of Pancreatic Intraductal Neoplasms?

The estimated prevalence of Pancreatic Intraductal Neoplasms is approximately 3358.2 per 100,000 population.

Deep-dive into Pancreatic Intraductal Neoplasms

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Pancreatic Intraductal Neoplasms — Drugs in Development & Clinical Trials | BioSniper